Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Chemizon, a division of Optomagic, has announced that Takeda Pharmaceutical Company has agreed to continue and further expand its current research collaboration that utilizes Chemizon's Discovery Platform. The expansion is effective as of April 1, 2008.
Subscribe to our email newsletter
Tony Piscopio, chairman and CEO of Optomagic, said: “We are pleased that Takeda has decided to further expand its partnership with Chemizon. With our recently announced strategic partnership in the area of oncology, we anticipate working with our partners and leveraging our integrated Discovery Platform.”